{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T09:35:18Z","timestamp":1769420118549,"version":"3.49.0"},"reference-count":81,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["101552"],"award-info":[{"award-number":["101552"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1088214"],"award-info":[{"award-number":["1088214"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1019693"],"award-info":[{"award-number":["1019693"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2017.00934","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T11:12:44Z","timestamp":1510830764000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["In Vitro and In Silico Risk Assessment in Acquired Long QT Syndrome: The Devil Is in the Details"],"prefix":"10.3389","volume":"8","author":[{"given":"William","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique J.","family":"Windley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie I.","family":"Vandenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam P.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jacc.2004.09.069","article-title":"Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil","volume":"45","author":"Aiba","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/sj.bjp.0706678","article-title":"Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin","volume":"147","author":"Alexandrou","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1161\/CIRCRESAHA.116.303975","article-title":"Control of cardiac repolarization by phosphoinositide 3-kinase signaling to ion channels","volume":"116","author":"Ballou","year":"2015","journal-title":"Circ. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/cvr\/cvp213","article-title":"Reverse rate dependency is an intrinsic property of canine cardiac preparations","volume":"84","author":"B\u00e1ny\u00e1sz","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1101\/100677","article-title":"Sinusoidal voltage protocols for rapid characterization of ion channel kinetics","author":"Beattie","year":"2017","journal-title":"bioRxiv"},{"key":"B6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0008-6363(02)00601-6","article-title":"beta3-adrenergic regulation of an ion channel in the heart-inhibition of the slow delayed rectifier potassium current I(Ks) in guinea pig ventricular myocytes","volume":"56","author":"Bosch","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"B7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0022-3565(25)12319-7","article-title":"Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872","volume":"276","author":"Bril","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3389\/fphys.2017.00597","article-title":"Quantitative comparison of effects of dofetilide, sotalol, quinidine, and verapamil between human ex vivo trabeculae and in silico ventricular models incorporating inter-individual action potential variability","volume":"8","author":"Britton","year":"2017","journal-title":"Front. Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"E2098","DOI":"10.1073\/pnas.1304382110","article-title":"Experimentally calibrated population of models predicts and explains intersubject variability in cardiac cellular electrophysiology","volume":"110","author":"Britton","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0022-3565(25)10827-6","article-title":"Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide","volume":"262","author":"Carmeliet","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1517\/14656566.1.5.947","article-title":"Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of induction hazardous cardiac dysrhythmias","volume":"1","author":"Cavero","year":"2000","journal-title":"Expert Opin. Pharmacother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"12461","DOI":"10.1073\/pnas.192367299","article-title":"Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels","volume":"99","author":"Chen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","article-title":"An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel","volume":"81","author":"Crumb","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1042\/BST0351060","article-title":"hERG channel trafficking: novel targets in drug-induced long QT syndrome","volume":"35","author":"Dennis","year":"2007","journal-title":"Biochem. Soc. Trans"},{"key":"B15","doi-asserted-by":"publisher","first-page":"H104","DOI":"10.1152\/ajpheart.00511.2012","article-title":"High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessment","volume":"304","author":"Di Veroli","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/jce.12289","article-title":"hERG inhibitors with similar potency but different binding kinetics do not pose the same proarrhythmic risk: implications for drug safety assessment","volume":"25","author":"Di Veroli","year":"2014","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.yjmcc.2014.05.013","article-title":"Ranolazine inhibition of hERG potassium channels: drug-pore interactions and reduced potency against inactivation mutants","volume":"74","author":"Du","year":"2014","journal-title":"J. Mol. Cell Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1021\/ci300353u","article-title":"Modeling of open, closed, and open-inactivated states of the hERG1 channel: structural mechanisms of the state-dependent drug binding","volume":"52","author":"Durdagi","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"B19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3389\/fphys.2017.00616","article-title":"Optimization of an in silico cardiac cell model for proarrhythmia risk assessment","volume":"8","author":"Dutta","year":"2017","journal-title":"Front. Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.22489\/CinC.2016.253-483","article-title":"Optimization of an in silico cardiac cell model for proarrhythmia risk assessment","author":"Dutta","year":"2016","journal-title":"Comput. Cardiol"},{"key":"B21","volume-title":"Note for Guidance on the Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs","author":"E14","year":"2005"},{"key":"B22","doi-asserted-by":"publisher","first-page":"093918","DOI":"10.1063\/1.5000226","article-title":"Revealing kinetics and state-dependent binding properties of IKur-targeting drugs that maximize atrial fibrillation selectivity","volume":"27","author":"Ellinwood","year":"2017","journal-title":"Chaos"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1087057115594589","article-title":"A new perspective in the field of cardiac safety testing through the comprehensive in vitro proarrhythmia assay paradigm","volume":"21","author":"Fermini","year":"2016","journal-title":"J. Biomol. Screen."},{"key":"B24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1161\/01.RES.82.3.386","article-title":"Molecular determinants of dofetilide block of HERG K+ channels","volume":"82","author":"Ficker","year":"1998","journal-title":"Circ. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yjmcc.2009.09.019","article-title":"A novel computational model of the human ventricular action potential and Ca transient","volume":"48","author":"Grandi","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.hrthm.2005.04.029","article-title":"Exaggerated block of hERG (KCNH2) and prolongation of action potential duration by erythromycin at temperatures between 37 degrees C and 42 degrees C","volume":"2","author":"Guo","year":"2005","journal-title":"Heart Rhythm"},{"key":"B27","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1124\/mol.114.091835","article-title":"Kinetics of drug interaction with the Kv11.1 potassium channel","volume":"85","author":"Hill","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1529\/biophysj.106.101956","article-title":"Mechanism of block of the hERG K+ channel by the scorpion toxin CnErg1","volume":"92","author":"Hill","year":"2007","journal-title":"Biophys. J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1161\/01.CIR.103.15.2004","article-title":"Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic","volume":"103","author":"Hondeghem","year":"","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0008-6363(01)00259-0","article-title":"Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmia","volume":"50","author":"Hondeghem","year":"","journal-title":"Cardiovasc. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1476-5381.2010.01181.x","article-title":"Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade","volume":"164","author":"Jia","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1124\/mol.60.2.244","article-title":"Open channel block of HERG K+ channels by vesnarinone","volume":"60","author":"Kamiya","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1161\/01.CIR.94.10.2572","article-title":"Molecular physiology and pharmacology of HERG. single-channel currents and block by dofetilide","volume":"94","author":"Kiehn","year":"1996","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.vascn.2004.06.003","article-title":"Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern","volume":"50","author":"Kirsch","year":"2004","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/cpt.367","article-title":"Improved prediction of drug-induced torsades de pointes through simulations of dynamics and machine learning algorithms","volume":"100","author":"Lancaster","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pbiomolbio.2015.12.005","article-title":"In silico assessment of kinetics and state dependent binding properties of drugs causing acquired LQTS","volume":"120","author":"Lee","year":"2016","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e004628","DOI":"10.1161\/CIRCEP.116.004628","article-title":"Improving the in silico assessment of proarrhythmia risk by combining hERG (Human Ether-a-go-go-Related Gene) channel-drug binding kinetics and multichannel pharmacology","volume":"10","author":"Li","year":"2017","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.yjmcc.2016.09.011","article-title":"Convergence of models of human ventricular myocyte electrophysiology after global optimization to recapitulate clinical long QT phenotypes","volume":"100","author":"Mann","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/01.fjc.0000246853.15926.d4","article-title":"In vitro preclinical cardiac assessment of tolterodine and terodiline: multiple factors predict the clinical experience","volume":"48","author":"Martin","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/01.fjc.0000129581.81508.78","article-title":"Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block","volume":"44","author":"Milberg","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.vascn.2010.02.007","article-title":"Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: cisapride vs dofetilide","volume":"61","author":"Milnes","year":"2010","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.vascn.2014.07.002","article-title":"Prediction of thorough QT study results using action potential simulations based on ion channel screens","volume":"70","author":"Mirams","year":"2014","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B43","doi-asserted-by":"publisher","first-page":"12329","DOI":"10.1073\/pnas.210244497","article-title":"A structural basis for drug-induced long QT syndrome","volume":"97","author":"Mitcheson","year":"","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1085\/jgp.115.3.229","article-title":"Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate","volume":"115","author":"Mitcheson","year":"","journal-title":"J. Gen. Physiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"98ra83","DOI":"10.1126\/scitranslmed.3002588","article-title":"A Computational model to predict the effects of class I anti-arrhythmic drugs on ventricular rhythms","volume":"3","author":"Moreno","year":"2011","journal-title":"Sci. Trans. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1161\/01.RES.87.11.1012","article-title":"Probing the interaction between inactivation gating and Dd-sotalol block of HERG","volume":"87","author":"Numaguchi","year":"2000","journal-title":"Circ. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e1002061","DOI":"10.1371\/journal.pcbi.1002061","article-title":"Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation","volume":"7","author":"O'Hara","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10557-012-6405-1","article-title":"Dofetilide promotes repolarization abnormalities in perfused Guinea-pig heart","volume":"26","author":"Osadchii","year":"2012","journal-title":"Cardiovasc. Drugs Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1124\/jpet.302.1.314","article-title":"Open channel block by KCB-328 [1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylam ino]ethane hydrochloride] of the heterologously expressed human ether-a-go-go-related gene K+ channels","volume":"302","author":"Park","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1124\/mol.108.049056","article-title":"Drug binding to the inactivated state is necessary but not sufficient for high-affinity binding to human ether-a-go-go-related gene channels","volume":"74","author":"Perrin","year":"","journal-title":"Mol. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.pbiomolbio.2008.10.006","article-title":"Human ether-a-go-go related gene (hERG) K+ channels: function and dysfunction","volume":"98","author":"Perrin","year":"","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1124\/mol.104.000117","article-title":"Structural determinants of HERG channel block by clofilium and ibutilide","volume":"66","author":"Perry","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"B53","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-3565(24)29223-5","article-title":"Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-a-gogo K+ channel","volume":"299","author":"Potet","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/1087057104264798","article-title":"Rb+ flux through hERG channels affects the potency of channel blocking drugs: correlation with data obtained using a high-throughput Rb+ efflux assay","volume":"9","author":"Rezazadeh","year":"2004","journal-title":"J. Biomol. Screen."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1540-8159.1998.tb00148.x","article-title":"Taking the \u201cidio\u201d out of \u201cidiosyncratic\u201d: predicting torsades de pointes","volume":"21","author":"Roden","year":"1998","journal-title":"Pacing Clin. Electrophysiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.yjmcc.2014.02.018","article-title":"In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome","volume":"72","author":"Romero","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B58","volume-title":"Note for Guidance on the Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals)","author":"S7B","year":"2005"},{"key":"B59","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","article-title":"Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the cardiac safety research consortium","volume":"167","author":"Sager","year":"2014","journal-title":"Am. Heart J."},{"key":"B60","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1109\/TBME.2010.2077292","article-title":"Effects of the antiarrhythmic drug dofetilide on transmural dispersion of repolarization in ventriculum. a computer modeling study","volume":"58","author":"Saiz","year":"2011","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"B61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/01.RES.68.1.77","article-title":"Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. mechanism of action","volume":"68","author":"Sanguinetti","year":"1991","journal-title":"Circ. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"24182","DOI":"10.1038\/srep24182","article-title":"New potential binding determinant for hERG channel inhibitors","volume":"6","author":"Saxena","year":"2016","journal-title":"Sci. Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.bpj.2008.10.056","article-title":"Parameter sensitivity analysis in electrophysiological models using multivariable regression","volume":"96","author":"Sobie","year":"2009","journal-title":"Biophys. J."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1038\/sj.bjp.0707356","article-title":"State dependent dissociation of HERG channel inhibitors","volume":"151","author":"Stork","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.yjmcc.2003.10.017","article-title":"Mesoridazine: an open-channel blocker of human ether-a-go-go-related gene K+ channel","volume":"36","author":"Su","year":"2004","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0014-5793(97)01030-2","article-title":"Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241","volume":"414","author":"Suessbrich","year":"1997","journal-title":"FEBS Lett."},{"key":"B67","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1088\/0031-9155\/51\/23\/014","article-title":"Cell model for efficient simulation of wave propagation in human ventricular tissue under normal and pathological conditions","volume":"51","author":"Ten Tusscher","year":"2006","journal-title":"Phys. Med. Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1152\/physrev.00036.2011","article-title":"hERG K+ channels: structure, function, and clinical significance","volume":"92","author":"Vandenberg","year":"2012","journal-title":"Physiol. Rev."},{"key":"B69","doi-asserted-by":"publisher","first-page":"C165","DOI":"10.1152\/ajpcell.00596.2005","article-title":"Temperature dependence of human ether-a-go-go-related gene K+ currents","volume":"291","author":"Vandenberg","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e001615","DOI":"10.1161\/JAHA.114.001615","article-title":"Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine, and verapamil","volume":"4","author":"Vicente","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"B71","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/sj.bjp.0702774","article-title":"Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states","volume":"128","author":"Walker","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1469-7793.1997.045bl.x","article-title":"A quantitative analysis of the activation and inactivation kinetics of HERG expressed in Xenopus oocytes","volume":"502","author":"Wang","year":"1997","journal-title":"J. Physiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"422.e10","DOI":"10.1016\/j.cell.2017.03.048","article-title":"Cryo-EM Structure of the open human ether-a-go-go-related K+ channel hERG","volume":"169","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"B74","doi-asserted-by":"publisher","first-page":"32536","DOI":"10.1038\/srep32536","article-title":"Role of the pH in state-dependent blockade of hERG Currents","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"B75","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.vascn.2017.02.017","article-title":"Measuring kinetics and potency of hERG block for CiPA","volume":"87","author":"Windley","year":"2017","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/mol.115.103127","article-title":"Temperature effects on kinetics of KV11.1 drug block have important consequences for in silico proarrhythmic risk prediction","volume":"90","author":"Windley","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.hrthm.2008.09.008","article-title":"Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine","volume":"5","author":"Wu","year":"2008","journal-title":"Heart Rhythm"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1124\/mol.115.098111","article-title":"The Link between inactivation and high-affinity block of hERG1 channels","volume":"87","author":"Wu","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.yjmcc.2016.08.011","article-title":"A computational model predicts adjunctive pharmacotherapy for cardiac safety via selective inhibition of the late cardiac Na current","volume":"99","author":"Yang","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1161\/01.CIR.91.6.1799","article-title":"Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. concentration-, time-, voltage-, and use-dependent effects","volume":"91","author":"Yang","year":"1995","journal-title":"Circulation"},{"key":"B81","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.vascn.2005.04.008","article-title":"Estimation of potency of HERG channel blockers: impact of voltage protocol and temperature","volume":"5","author":"Yao","year":"2005","journal-title":"J. Pharmacol. Toxicol. Methods"}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphys.2017.00934\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T01:24:55Z","timestamp":1750987495000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphys.2017.00934\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,16]]},"references-count":81,"alternative-id":["10.3389\/fphys.2017.00934"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2017.00934","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,16]]},"article-number":"934"}}